Vir Biotechnology, Inc.
NASDAQVir Biotechnology heads into its May 26 earnings date with options traders the most defensively positioned they have been all year — even as short sellers quietly trim their exposure. The options signal is the sharpest tension in the current setup. The put/call ratio has climbed to 0.79, a 52-week high, and is running more than 1.5 standard deviations above its 20-day average of…
Snapshot as of 7 May 2026
Vir Biotechnology heads into its May 26 earnings date with options traders the most defensively positioned they have been all year — even as short sellers quietly trim their exposure. The options signal is the sharpest…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for VIR — free to start on ORTEX.
Sign up for free →Open VIR on ORTEX